A high-level overview of Amphastar Pharmaceuticals, Inc. (AMPH) stock. View (AMPH) real-time stock price, chart, news, analysis, analyst reviews and more.

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual ...

Exposure to stress triggers hormonal and behavioral responses. It has been shown that the endogenous opioid system plays a role in some physiological reactions to stress. The opioid system was ...

On June 24, 2025, Cambridge Healthcare Innovations (CHI), a start-up developing inhaler technology, announced that its dry powder inhaler (DPI) engine, Quattrii, is the first of its kind to deliver ...

CHARLOTTE, N.C. (WKRC) - An American Airlines statement said that an odor reported at an airport led to several crew members being hospitalized with inhalation symptoms, NBC News and PEOPLE reported.

Seven people were hospitalized with minor injuries on after inhaling what officials are calling an 'unknown substance' from an American Airlines aircraft at a North Carolina airport on June 27.

Among patients with pulmonary arterial hypertension, once-daily treprostinil palmitil inhalation powder for 16 weeks reduced pulmonary vascular resistance and improved 6-minute walk distance ...

Inhalation dosing, by contrast, removes the risk of intratracheal artefacts by delivering compounds to conscious animals via the clinical route of administration – namely, the lung.

What is nitrous oxide? Nitrous oxide is used in a medical settings as an anesthetic and analgesic, according to WebMD. It is also used in aerosol whipped cream dispensers.

On Friday, June 27, several airline and airport employees were transported to a local hospital for "inhalation symptoms of an unknown substance from an aircraft," the Mecklenburg Emergency Medical ...

Leveraging its innovative gene therapy vectors expressing CA8* analgesic peptides (ADLR-1001), Adolore is currently advancing two preclinical development programs: ADB-101 for the treatment of ...